1. Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer
   Lucile Pabst et al, 2023, International Journal of Molecular Sciences CrossRef
2. Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas
   Mario Sánchez-Canteli et al, 2022, International Journal of Molecular Sciences CrossRef
3. Mechanistic rationales for combining immunotherapy with radiotherapy
   Alexander Chi et al, 2023, Frontiers in Immunology CrossRef
4. Classification of Non-Small Cell Lung Cancer’s Tumor Immune Micro-Environment and Strategies to Augment Its Response to Immune Checkpoint Blockade
   Alexander Chi et al, 2021, Cancers CrossRef
5. Strategies to overcome DC dysregulation in the tumor microenvironment
   Guillaume Mestrallet et al, 2022, Frontiers in Immunology CrossRef
6. Nuclear Dishevelled: An enigmatic role in governing cell fate and Wnt signaling
   Geetha Priya Boligala et al, 2022, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
7. Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer
   Nerea Otegui et al, 2023, Cancers CrossRef
8. Aberrant Expression of β-Catenin Correlates with Infiltrating Immune Cells and Prognosis in NSCLC
   Hongmei Zheng et al, 2021, Pathology and Oncology Research CrossRef
9. Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling
   Maliheh Entezari et al, 2022, Biomedicine & Pharmacotherapy CrossRef
10. Implication of changes in PD-L1 expression during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF) regimen in esophageal squamous cell carcinoma
    Seiichiro Mitani et al, 2023, Esophagus CrossRef
11. Targeting Wnt/β-catenin signaling using XAV939 nanoparticles in tumor microenvironment-conditioned macrophages promote immunogenicity
    Chetan Pundkar et al, 2023, Heliyon CrossRef
12. Efficacy of Immune-checkpoint Inhibitors as the Peri-operative Treatment for Resectable Non-small-cell Lung Cancer
    Hiroyuki Suzuki et al, 2021, Haigan CrossRef
13. Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers
    Satoshi Muto et al, 2023, Biomedicines CrossRef